Cibus, Inc. announced that the Company is moving forward in the next step of commercialization of its developed traits. 2023 field trial results have confirmed that rice herbicide tolerance (HT) traits, known as HT1 and HT3, met or exceeded performance expectations when evaluated with proposed commercial herbicide application rates. This important step in commercial development has led to the first transfers of customer seeds containing the HT1 and HT3 traits.

Additional transfers of both HT traits to seed developers are in progress and this will enable a broad offering of rice hybrids and varieties in the US and international markets in the coming years. Cibus expects to have field scale demonstrations of the HT rice traits in the US Mid-South in 2024 and expand to other geographies in 2025. Cibus also reported that its canola Pod Shatter Reduction (PSR) trait in seed developer genetics performed well and on par with the best available in the industry.

Concurrent with the positive field trial results, seed developer lines containing the PSR trait were transferred to multiple companies in 2023 and further transfers are planned in 2024. This important development continues to enable production and testing of seed developer PSR hybrids in 2024, leading to first hybrid sales as early as 2025. Meanwhile, Cibus expects the first field results of its PSR trait in WOSR in the United Kingdom later this year.

Industry leading PSR traits are still not broadly available in the canola/WOSR markets despite years of industry research. Cibus intends to change this by broadly licensing its PSR trait to canola/WOSR seed developers globally, and already has 10 seed developer?s genetics at various stages of gene editing. A key element of Cibus?

technology breakthrough is its High Throughput Breeding Process (referred to as the Trait Machine? System). The Trait Machine process is a crop specific application of Cibus?

patented Rapid Trait Development System? (RTDS®). The proprietary technologies in RTDS integrate crop specific cell biology platforms with a series of gene editing technologies to enable a system of end-to-end crop specific precision breeding.

It is the core technology platform for Cibus? Trait Machine: the first standardized end-to-end semi-automated crop specific gene editing system that directly edits a seed company?s elite germplasm. Each Trait Machine process requires a crop specific cell biology platform that enables Cibus to edit a single cell from a customers?

elite germplasm and grow that edited cell into a plant with the Cibus edits. Cibus has Trait Machine platforms developed for canola and rice and has already begun transferring their elite germplasm with Cibus edits back to customers. The traits from Cibus?

RTDS-based High Throughput Breeding System are indistinguishable from traits developed using conventional breeding or from nature. RTDS does not use any foreign DNA or transgenes. Under the European Commission current proposals, it is expected that products from Cibus?

RTDS gene editing platform such as its pod shatter reduction trait and Sclerotinia resistance traits for Canola and Winter Oilseed Rape would be considered ?Conventional-like'.